Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength

vs
industry
vs
history
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth

vs
industry
vs
history
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.

Ratios

vs
industry
vs
history
PE Ratio 22.37
XPH's PE Ratio is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. XPH: 22.37 )
Ranked among companies with meaningful PE Ratio only.
XPH' s PE Ratio Range Over the Past 10 Years
Min: 0  Med: 0 Max: 31.71
Current: 22.37
0
31.71
PE Ratio without NRI 22.37
XPH's PE Ratio without NRI is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. XPH: 22.37 )
Ranked among companies with meaningful PE Ratio without NRI only.
XPH' s PE Ratio without NRI Range Over the Past 10 Years
Min: 0  Med: 0 Max: 31.71
Current: 22.37
0
31.71
PB Ratio 2.33
XPH's PB Ratio is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. XPH: 2.33 )
Ranked among companies with meaningful PB Ratio only.
XPH' s PB Ratio Range Over the Past 10 Years
Min: 0  Med: 0 Max: 2.79
Current: 2.33
0
2.79

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield % 0.60
XPH's Dividend Yield % is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. XPH: 0.60 )
Ranked among companies with meaningful Dividend Yield % only.
XPH' s Dividend Yield % Range Over the Past 10 Years
Min: 0  Med: 0 Max: 0.66
Current: 0.6
0
0.66
5-Year Yield-on-Cost % 0.60
XPH's 5-Year Yield-on-Cost % is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. XPH: 0.60 )
Ranked among companies with meaningful 5-Year Yield-on-Cost % only.
XPH' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0  Med: 0 Max: 0.66
Current: 0.6
0
0.66

More Statistics

Short Percentage of Float0.00%
52-Week Range $36.67 - 47.65
Shares Outstanding (Mil)11,300,270.00
» More Articles for XPH

Headlines

Articles On GuruFocus.com
Royce Funds Commentary: 4 Elements of Small-Cap Risk Management Mar 24 2017 
Bruce Berkowitz Buys More Shares of Sears Mar 23 2017 
What Happens If Trump Fails? Mar 23 2017 
The Most Attractive Value Stock There Is? Mar 23 2017 
Eddie Lampert's Statement on Sears Outlook Mar 23 2017 
Weekly CFO Sells Highlights Mar 23 2017 
Royal Bank of Canada Downgrades Altria Group Mar 23 2017 
Franco-Nevada Releases 2016 Figures Mar 23 2017 
Northgate Trades at P/E of 12 With a 3% Dividend Yield Mar 23 2017 
Insiders Load Up on Pulse Biosciences Mar 23 2017 

More From Other Websites
Trump, Biogen and Amgen Hammer Healthcare ETFs Mar 20 2017
Analyzing Bristol-Myers Squibb’s 2016 Performance Mar 16 2017
Should You Buy Pharma ETFs Now? Mar 15 2017
Johnson & Johnson’s Financial Guidance for 2017 Mar 15 2017
Aurinia’s stock plunges after big share offering at deep discount Mar 14 2017
Trump Tweet on Drug Pricing Hits Biotech and Pharma ETFs Mar 08 2017
Stocks Fall for Day Two as Trump Targets Health Care Sector Mar 07 2017
Pharma and biotech stocks slump after President Trump tweets about lowering drug prices Mar 07 2017
How Mylan Is Valued after 4Q16 Earnings Mar 06 2017
Best & Worst ETFs of February 2017 Mar 01 2017
Investors have stopped believing Trump’s drug price threats Mar 01 2017
Bernie Sanders has some new allies in fight to bring Canadian drugs to the U.S. Mar 01 2017
Pieris Pharmaceuticals' stock soars after exclusive license deal with Japan's ASKA Feb 27 2017
La Jolla Pharmaceutical's stock rockets in active trade after positive trial results Feb 27 2017
Eli Lilly & Co.’s Cardiovascular Franchise Feb 24 2017
Gardasil Driving Merck & Co.’s Vaccines Business in 4Q16 Feb 23 2017
Drug stocks dip after Spicer affirms Trump’s stance on cutting costs Feb 07 2017
Q4 Earnings Faring Well for Pharma ETFs Feb 06 2017
What to Expect from Eli Lilly’s Cardiovascular Franchise in 4Q16 Jan 26 2017
A.M. Funds Roundup: Investors Buy Volatility ETFs, Exit Equity ETFs Ahead Of Inauguration, Jan 20 2017

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK